首页> 外文会议>Optical methods for tumor treatment and detection: mechanisms and techniques in photodynamic therapy XXVI >Real Time Laser Speckle Imaging Monitoring Vascular Targeted Photodynamic Therapy
【24h】

Real Time Laser Speckle Imaging Monitoring Vascular Targeted Photodynamic Therapy

机译:实时激光散斑成像监测血管靶向光动力疗法

获取原文
获取原文并翻译 | 示例

摘要

Laser speckle imaging is a technique that has been developed to non-invasively monitor in vivo blood flow dynamics and vascular structure, at high spatial and temporal resolution. It can record the full-field spatio-temporal characteristics of microcirculation and has therefore, often been used to study the blood flow in tumors after photodynamic therapy (PDT). Yet, there is a paucity of reports on real-time laser speckle imaging (RTLSI) during PDT. Vascular-targeted photodynamic therapy (VTP) with WST11, a water-soluble bacteriochlorophyll derivative, achieves tumor ablation through rapid occlusion of the tumor vasculature followed by a cascade of events that actively kill the tumor cells. WST11-VTP has been already approved for treatment of early/intermediate prostate cancer at a certain drug dose, time and intensity of illumination. Application to other cancers may require different light dosage. However, incomplete vascular occlusion at lower light dose may result in cancer cell survival and tumor relapse while excessive light dose may lead to toxicity of nearby healthy tissues. Here we provide evidence for the feasibility of concomitant RTLSI of the blood flow dynamics in the tumor and surrounding normal tissues during and after WST11-VTP. Fast decrease in the blood flow is followed by partial mild reperfusion and a complete flow arrest within the tumor by the end of illumination. While the primary occlusion of the tumor feeding arteries and draining veins agrees with previous data published by our group, the late effects underscore the significance of light dose control to minimize normal tissue impairment. In conclusion- RTSLI application should allow to optimize VTP efficacy vs toxicity in both the preclinical and clinical arenas.
机译:激光散斑成像技术已被开发为以高空间和时间分辨率无创地监测体内血流动力学和血管结构。它可以记录微循环的全时空时空特征,因此经常被用于研究光动力疗法(PDT)后肿瘤中的血流。然而,关于PDT期间的实时激光散斑成像(RTLSI)的报道很少。水溶性细菌叶绿素衍生物WST11的血管靶向光动力疗法(VTP)通过快速阻塞肿瘤脉管系统并随后一系列主动杀死肿瘤细胞的事件来实现肿瘤消融。 WST11-VTP已被批准以一定的药物剂量,时间和照射强度治疗早期/中度前列腺癌。应用于其他癌症可能需要不同的光剂量。然而,较低的光剂量不完全的血管闭塞可能导致癌细胞存活和肿瘤复发,而过量的光剂量则可能导致附近健康组织的毒性。在这里,我们提供了在WST11-VTP期间和之后伴随肿瘤和周围正常组织血流动力学的RTLSI可行性的证据。血流迅速减少,随后局部轻度再灌注,并在照明结束时在肿瘤内完全停止血流。尽管肿瘤的供血动脉和引流静脉的主要闭塞与我们小组先前发表的数据一致,但后期的影响强调了光剂量控制的重要性,以最大程度地减少正常组织损伤。总之,RTSLI的应用应允许在临床前和临床领域优化VTP功效与毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号